Shawn Fojtik is an entrepreneur, medical device inventor and investor with over 100+ combined issued and patents pending. He is the co-founder of over 12 medical technology companies including: Control Medical, Distal Access, CIRCA Scientific, Pinyons Medical, Transit Scientific, Fluidx Medical, Pivot Science, Axiom, Occam Scientific and PMT Partners.

He is currently the CEO of Control Medical Technology, an award-winning platform used to remove blood clots during heart attack, peripheral vascular disease, deep vein thrombosis, and stroke. He is also the CEO and co-founder of Distal Access, the developer of the SPINR high-performance Guidewire Controller, sold to Merit Medical in 2015 and the Resectr Tissue Resection Device, which was sold to Boston Scientific in 2016.

He has clinical experience in the fields of cardiology, interventional radiology and oncology, women’s health, electrophysiology, embolics, biopsy, among others.

He is an Adjunct Assistant Professor of Surgery at the University of Utah and has a BS from University of Illinois and an advanced degree from Harvard University.